Avanti Biosciences, Inc. is a private biotechnology company located in Long Island (New York) and established in 2009. It is dedicated to discovering and developing innovative therapies for patients with debilitating diseases, particularly through the use of new chemical entities (NCE) derived from natural products to make them more bioavailable and selective. The scientific founders of Avanti are highly regarded in the field of drug discovery and clinical development, known for their exceptional track record in translating research into breakthrough science and therapeutics. Avanti's scientific discoveries hold promise for a wide range of therapeutic applications, including cancer, allergy, and inflammation. The company operates in the pharmaceutical industry and has not disclosed its latest investment details or investors.
There is no investment information
No recent news or press coverage available for Avanti Biosciences, Inc..
We care about your data, and we'd love to use cookies make your experience better.